Vivoryon Therapeutics N.V. (AMS:VVY)

Revenue by Product

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2021
Therapeutic Products	-3.62M	Log In
Therapeutic Products Growth	-133.63%	Log In

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2021
Germany	-3.62M	Log In
Greater China	-	Log In